Search

everythinglearnresearchcommunity

for

Search:↓

The cause of Frontal fibrosing alopecia, a type of hair loss, is complex, likely involving immune responses and genetics, but is not fully understood.

Some people developed alopecia areata after COVID-19 vaccination, but it's not caused by the vaccine and most improved with treatment.

Alopecia areata severely impacts quality of life, mental health, and work productivity.

COVID-19 vaccines can trigger autoimmune flares but are still beneficial for patients with autoimmune conditions.

People with alopecia who are more resilient tend to feel less stressed.

Thymoma-associated multiorgan autoimmunity can cause liver damage and affects multiple organs, with limited treatment options and a generally poor prognosis.

A combination of ciclosporin and ketoconazole can effectively treat severe hair loss in dogs.

Low-level laser therapy can significantly regrow hair in alopecia areata.

Early treatment with corticosteroids improved her eye condition significantly.

The document concludes that Telogen Effluvium is a hair loss disorder that can be assessed with the modified wash test and may be treated with clobetasol foam, with patient management being important.

The 2004 hair research meeting presented new findings on hair cell differentiation, genetic factors in hair loss, hair pigmentation, and potential targeted therapies.

Advancements in hair biology include new treatments and tools for hair growth and alopecia.

Androgens may influence T cells, contributing to higher autoimmune liver disease risk in women.

γδTregs may help treat autoimmune diseases like alopecia areata by promoting hair regrowth and reducing immune attacks.

New hair loss treatments could be improved by using combined biological markers.

Low-dose methotrexate is generally safe but can cause mild to severe side effects, and folic acid can reduce these risks.

Early treatment and multidisciplinary care are key to managing Frontal Fibrosing Alopecia and preventing further hair loss.

Vogt-Koyanagi-Harada disease can develop during interferon therapy for chronic hepatitis C.

Losing eyelashes or eyebrows can be a sign of many different health problems and needs a careful approach to treat effectively.

Baricitinib successfully treated severe hair loss.

Anti-TNF-α therapy may increase the risk of developing alopecia areata, especially in those with a history of autoimmune disease.

Herpes simplex virus infections should be considered in pemphigus patients to avoid unnecessary changes in treatment.

IVIG therapy significantly improved symptoms in a patient with APS-2 and SPS.

Two unusual cases showed that Lichen Planopilaris can look like other skin conditions and need early treatment to protect hair.

Environmental factors like diet and vitamin levels, especially Vitamin D, can affect autoimmune diseases differently, with lifestyle changes potentially improving outcomes.

An imbalance between certain immune cells is linked to a chronic skin condition and may be influenced by obesity, smoking, and autoimmune issues.

Patients with one autoimmune disease should be checked for other autoimmune disorders.

The combination therapy of microdermabrasion and steroid injections is more effective for treating scalp Alopecia Areata than steroid injections alone.

Alopecia areata is a hair loss condition that may be linked to stress and genetics, often requires psychological support, and has no set treatment.

Increasing regulatory T cells may help treat alopecia areata by reducing autoimmunity and promoting hair growth.